AIM
DTIL icon

Alambic Investment Management’s Precision BioSciences DTIL Stock Holding History

Alambic Investment Management’s Portfolio DTIL Stock Details DTIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-381
Closed -$95K – 98
2020
Q2 		$95K Sell
381
-37
-9% -$8.1K 0.24% 133
2020
Q1 		$76K Sell
418
-323
-44% -$84.6K 0.18% 145
2019
Q4 		$309K Buy
+741
New +$233K 0.26% 160

Other funds holding DTIL

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WHAM
Windmill Hill Asset Management Waddesdon, United Kingdom $321M AUM 25.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Alambic Investment Management's DTIL Position: Q3 2020 in Review

Alambic Investment Management sold out of Precision BioSciences (DTIL) in Q3 2020, closing a stake of 381 shares — an estimated $95K sold.

Alambic Investment Management first reported a position in DTIL in Q4 2019 and held it in 3 quarters. The position peaked at $309K in Q4 2019. 116 funds tracked by Wall St. Rank hold DTIL as of Q3 2020.

  • Alambic Investment Management reported no remaining Precision BioSciences position as of Q3 2020 after selling out during the quarter.
  • Alambic Investment Management sold 381 Precision BioSciences shares in Q3 2020, an estimated $95K.
  • Alambic Investment Management first reported a position in Precision BioSciences in Q4 2019 and held it in 3 quarters.
  • Alambic Investment Management's Precision BioSciences position peaked at $309K in Q4 2019.
  • 116 funds tracked by Wall St. Rank held Precision BioSciences as of Q3 2020.

Based on Alambic Investment Management's 13F filing for Q3 2020, filed 13 Nov 2020.